APA (7th ed.) Citation

S, G., RE, R., JA, K., KR, R., C, W., AL, A., . . . ML, L. (2025). Blinatumomab in Standard-Risk B-Cell Acute Lymphoblastic Leukemia in Children. The New England journal of medicine, 392(9), 875. https://doi.org/10.1056/NEJMoa2411680

Chicago Style (17th ed.) Citation

S, Gupta, et al. "Blinatumomab in Standard-Risk B-Cell Acute Lymphoblastic Leukemia in Children." The New England Journal of Medicine 392, no. 9 (2025): 875. https://doi.org/10.1056/NEJMoa2411680.

MLA (9th ed.) Citation

S, Gupta, et al. "Blinatumomab in Standard-Risk B-Cell Acute Lymphoblastic Leukemia in Children." The New England Journal of Medicine, vol. 392, no. 9, 2025, p. 875, https://doi.org/10.1056/NEJMoa2411680.